Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
This is a syndrome most GPs regard as something you just have to put up with and unaware of Adartrel ® (Ropinirol) (GoldsmithKline) a dopaminagonist, which is already used for the treatment of the Parkinson illness. The drug has been used in the US and Europe and is now about to be introduced into the UK
The syndrome of the jerky legs, also Restless Legs syndrome (RLS) is a sensitive motor neurological disturbance, which is frequently misjudged and underestimated, although 5 - 15% of the European population are affected by it. It causes unpleasant feelings, mostly within the range of the legs, whereby the sleep is impaired and is associated with behaviour disturbances such as fear, as well as depression in the long run.
The complaints can begin at any age, although it is found frequently in the thirty something demographic. Many patients report acute symptoms to their podiatists but rarely mention the symptoms to their doctor until they are chronic. The illness is idiopathic and predominantly arises with a genetic predisposition. Research indicates RLS is caused by a disturbance in the dopamine metabolism and patients respond frequently to a dopamine type treatment.
Interested to find what experience podiatrists have had with patients and restless leg syndrome?
__________________
Craig Payne
Department of Podiatry
La Trobe University
Melbourne, Australia http://www.latrobe.edu.au/podiatry
__________________________________________________ ___________________________________ God put me on this earth to accomplish a certain number of things - right now I am so far behind, I will never die.
The views expressed above are those of the author and not that of La Trobe University This is where I am, where are you?
I am not a physician, but I do have restless leg syndrome, and additionally experienced cramping of toes and feet daily since childhood. In my case, the entire problem was solved within a couple of days by taking powdered magnesium. No one was more surprised than I. I take 1 tablespoon dissolved in hot water every evening, (in the morning as well during ski vacations or when I am over-tired) and have no symptoms. Been taking it for over 10 years now.
I have no studies or medical evidence to prove it works for everyone, but it would be an inexpensive, non-drug solution to try.
Last edited by Admin : 24th January 2009 at 02:12 PM.
Reason: removed link drop
The Following User Says Thank You to P Thompson For This Useful Post:
Reuters are reporting: Requip eases restless legs, study confirms
Quote:
February 2, 2006 10:23:34 AM PST
A large study confirms that restless legs syndrome (RLS) markedly reduces quality of life and interferes with sleep and that the drug Requip provides significant improvement in symptoms of RLS.
"Sleep is important for its restorative properties and treatment of RLS with Requip improves symptoms, sleep disturbance and quality of life in most RLS patients," Dr. Richard Bogan told Reuters Health.
Requip, also known as ropinirole, was approved in May 2005 by the US Food and Drug Administration for the treatment of RLS.
Bogan, of SleepMed of South Carolina in Columbia and colleagues conducted a blinded placebo-controlled study of Requip in 381 patients with RLS. Subjects took Requip or placebo 1 to 3 hours before bedtime.
At 12 weeks, the average score on the International Restless Legs Scale -- a validated instrument with a maximum severity of 40 -- had fallen from 22.0 to 8.4 in the Requip group, and from 21.6 to 11.9 in the placebo group. These differences were significant, the investigators note in a report in Mayo Clinic Proceedings.
Moreover, a significantly greater number of patients taking Requip than placebo were "much" or "very much" improved on the Clinical Global Improvement impression score.
Subjective measures of sleep disturbance, quality of life, and anxiety were also significantly improved with Requip.
This and other trials, the investigators conclude, show that Requip "is an effective and generally well-tolerated treatment for moderate to severe primary RLS."
A pt of mine seems to have minimised her RLS to a manageable point by following an extremely low salt,magnesium rich diet. I don't have exact details of the diet but I know she ordered the book over the internet. Whether it's placebo or not I'm not sure, but it seems to have helped.
As a podiatrist who also experiences periodic bouts of RLS, I have had good results both for myself and patients treating with 100 - 300 mg gabapentin before bed. As a side note, although my symptoms became significant around age 36, I do recall a couple of instances of RLS as a child. A patient of mine had similar experience.
Introduction
Restless legs syndrome (RLS) is a common cause of sleep disruption that has a significant impact on daytime function. As such, RLS is important not only to sleep specialists, but also to primary care practitioners and a wide array of specialists who treat disorders that may cause or be associated with RLS. Because RLS is a sensorimotor disorder, it is also important to neurologists.
New Importance of Restless Legs Syndrome
RLS was first described in the medical literature in 1945 in Ekbom's pioneering monograph[1] -- which still merits reading for its diversity of case studies -- but it has only been in the past 10 years that RLS has become generally recognized as a significant medical problem. This increased attention was coupled with the recent approval in the United States and Europe of ropinirole for the treatment of RLS; a levodopa compound was approved earlier in Germany, Switzerland, and Austria.[2] If the trend observed with current therapeutic trials is any indication, this pioneer treatment will be followed by others in the next few years. This development draws attention not only to the presence of a large patient base for RLS, but also to the ability to effectively treat the disorder.
Outline of Clinical Update
This Clinical Update will first cover the diagnostic features of RLS and the means of diagnosing RLS. Second, what is known about the prevalence of RLS and its causes will be examined. Finally, the current understanding of how to treat RLS, including tailoring the treatment to the various ways in which RLS can present, will be discussed.
Pretty amazing stuff. Apparently solves a myriad of problems, not just RLS, although a drug-free solution to RLS isn't a minor accomplishment. I buy the stuff in bulk
The BBC are reporting: Drug for Restless Legs Syndrome
Quote:
A drug to treat Restless Legs Syndrome has become the first to be granted a European licence.
The condition, a disorder of the nerves, causes a tingling, itching sensation, and unexplained aches and pains in the lower limbs.
It has been estimated that it affects as many as 10% of the population.
The new drug, Mirapexin, has been approved for use by the European Medicines Agency to treat moderate or severe cases.
It has still to be approved by the UK authorities. There are currently no other medications licensed for the treatment of Restless Legs Syndrome (RLS) in the UK. RLS, also known as Ekbom's syndrome, can affect one or both legs, and symptoms are sometimes felt in the arms as well.
They are most likely to be experienced at night, occasionally meaning the sufferer cannot fall asleep easily, and will often have a strong desire to get up and walk about.
Another symptom associated with RLS are involuntary leg movements, particularly when asleep, which can lead to the sufferer kicking out and waking either themselves or their sleeping partner.
US research found people with diabetes were at particular risk, as were those who did little exercise.
Some symptoms can be relieved by applying heat pads. The condition can also be prevented by cutting down on alcohol and caffeine.
Dr Ray Chaudhuri is a consultant neurologist and head of the National RLS Clinic at King's College Hospital, London - the only specialist clinic of its type in the UK.
He said the lack of sleep associated with restless leg syndrome could have profound implications.
"The disruption can lead to excessive daytime sleepiness, compromised work performance and significantly impact on quality of life.
"The consequences of constant sleep interruptions can be devastating for some people, as the tiredness and lack of concentration can led to depression.
"There is a real need for effective treatments and the introduction of Mirapexin is very welcome news for patients more severely affected by the condition."
However, Dr Chaudhuri said only around 500,000 of the estimated 4m sufferers in the UK were likely to benefit from the drug.
He said doctors currently treated the condition with a range of drugs, but none of these had been licensed.
Some doctors were reluctant to use these medications, as they were used, in much bigger doses, to treat Parkinson's patients.
Mirapexin, produced by Boehringer Ingelheim, is unlikely to be considered by the NHS drug watchdog, the National Institute for Health and Clinical Excellence, for at least a year.
Restless legs is only one of many symptoms of magnesium deficiency. the others are: fatigue, anxiety, insomnia, palpitations especially frequent ventricular ectopics, myocardial infarcts, hypertension, headaches and migraines etc. Magnesium is depleted by alcohol, exercise, sweating and excess calcium. Recommended intake is 250-300mg/day. average intake is 220mg/day so deficiency is not uncommon. Main dietary sources are greens (middle of chlorophyll molecule is magnesium), nuts and seeds, whole grains, which many people eat very little of. Usual supplemental dose is 300 - 600mg/day but much more is safe. To relieve restless legs use 200mg three times a day for 2-3 weeks, then reduce to 300mg/day with at least 200mg at bedtime as it is natures tranquillizer. It's cardiovascular benefits are due to its properties as natures calcium channel blocker.
Restless legs is only one of many symptoms of magnesium deficiency. the others are: fatigue, anxiety, insomnia, palpitations especially frequent ventricular ectopics, myocardial infarcts, hypertension, headaches and migraines etc. Magnesium is depleted by alcohol, exercise, sweating and excess calcium. Recommended intake is 250-300mg/day. average intake is 220mg/day so deficiency is not uncommon. Main dietary sources are greens (middle of chlorophyll molecule is magnesium), nuts and seeds, whole grains, which many people eat very little of. Usual supplemental dose is 300 - 600mg/day but much more is safe. To relieve restless legs use 200mg three times a day for 2-3 weeks, then reduce to 300mg/day with at least 200mg at bedtime as it is natures tranquillizer. It's cardiovascular benefits are due to its properties as natures calcium channel blocker.
The best source I've found for Magnesium is a water soluable powder from HERE
An elderly patient of mine was suffering from night cramps in her legs. She started to take a supplement (from health shop) that was advertised to help with hair and skin strength. She took it to improve the appearance of her hair. Once she started taking the tablets the night cramps stopped. I can't remember the exact contents of the supplement but I do know there was a high percentage of magnesium and zinc. Does zinc also help with cramps or is it more likely that the magnesium was producing the desired results? Does anyone recommend supplements if people are suffering from night cramps?
An elderly patient of mine was suffering from night cramps in her legs. She started to take a supplement (from health shop) that was advertised to help with hair and skin strength. She took it to improve the appearance of her hair. Once she started taking the tablets the night cramps stopped. I can't remember the exact contents of the supplement but I do know there was a high percentage of magnesium and zinc. Does zinc also help with cramps or is it more likely that the magnesium was producing the desired results? Does anyone recommend supplements if people are suffering from night cramps?
For me it's magnesium, no question. For night cramps especially.
For me it's magnesium, no question. For night cramps especially.
Absolutely agree - magnesium is the one for cramps and restless legs, but you need calcium as well for the cramps. 500mg calcium (as citrate not carbonate as its poorly absorbed) and 250mg magnesium. Good supplements will have that ratio. It's good to take half of the daily dose at bedtime so the calcium is there for the night-time parathyroid hormone. Check that they aren't coeliac - there are 8 undiagnosed for every one diagnosed, and oldest one diagnosed was in her 90s. Coeliac disease causes malabsorption of most minerals, and they usually present with vague complaints eg fatigue, anaemia, irritable bowel and osteoporosis. There's a very good blood test for it nowadays, called transglutaminase, that a GP can order. On the other hand, zinc is excellent for growing pains in children. 15-30mg daily should stop them within a month.
Last edited by METaylor : 31st October 2006 at 04:53 AM.
Reason: need to add some dosages
Ivanhoe Medical News are reporting: Restless Leg Drug may Cause Compulsive Gambling
Quote:
Roughly 3 million U.S. adults are problem gamblers, according to the National Council on Problem Gambling. Now, a new study reveals a type of medication used to treat restless legs syndrome could add to that number.
Researchers from the Mayo Clinic in Rochester, Minn., report a small number of patients became compulsive gamblers after starting treatment for restless legs syndrome, also known as RLS. The three patients were taking dopamine agonists, a class of medications used to treat restless legs syndrome and Parkinson's.
Dopamine agonists essentially mimic the behavior of dopamine in the brain. Dopamine helps the brain control movements, which is why patients with Parkinson's disease are prescribed dopamine agonists. Dopamine is also involved in the reward functions of the brain. The newest medications of this kind, pramipexole (Mirapex) and ropinirole (Requip), target the motivation, emotion, and reward centers of the brain. Researchers speculate the strong stimulation of those areas of the brain encourage patients to seek out pleasurable behaviors, like gambling.
Mayo Clinic researchers describe the case of a woman who, after starting treatment for restless legs syndrome, developed an uncontrollable urge to gamble. The patient reported no previous history of gambling. She eventually gambled away more than $140,000. Once she stopped taking ropinirole, she completely lost the urge to gamble.
Science Daily are reporting: Restless Legs Syndrome Affects Nearly Two Percent Of US And UK Children
Quote:
Restless legs syndrome is a common problem in children 8 years of age and older in the United States and the United Kingdom, according to a new report from an international team of researchers.
Nearly 2 percent of children aged 8 to 17 are affected, and a significant proportion of those experience moderate to severe symptoms, including sleep disturbance and negative moods. The report appears in the August issue of the journal Pediatrics.
"This study suggests that restless legs syndrome is common and troublesome in children and adolescents, occurring more frequently than diabetes and epilepsy," said principal investigator Daniel Picchietti, a professor of pediatrics in the University of Illinois College of Medicine and a pediatrician and sleep medicine specialist with the Carle Clinic Association and Carle Foundation Hospital in Urbana, Ill.
Restless legs syndrome (RLS) is a neurological sleep disorder characterized by sensations in the legs that create an urge to move. Symptoms are typically worse at night and during rest. RLS is closely associated with another condition, periodic limb movement disorder, in which a person's legs jerk during sleep. Some people with periodic limb movement disorder also have RLS. Others lack the sensations in the legs that typify RLS.
Most of what is known about restless legs syndrome comes from research on adults. The new analysis is the first population-based prevalence study of RLS in children, and it is the first to use specific pediatric diagnostic criteria. The research team collected detailed data from 10,523 families in the U.S. and U.K.
The new study affirmed that there is a strong genetic component to RLS, Picchietti said. More than 70 percent of the children with RLS had at least one parent with the condition. In 16 percent of the affected children, both parents had RLS symptoms.
Two recent studies -- appearing in July in the New England Journal of Medicine and in Nature Genetics -- found genes associated with RLS.
"Restless legs syndrome runs in families. That is one of the major points of our study, and the discovery of associated genes really supports it," Picchietti said.
Awareness of RLS in adults is increasing (depictions of -- and jokes about -- RLS are appearing more frequently in popular culture). It is less recognized in children, however, and parents and clinicians sometimes dismiss children's complaints about unusual sensations in their legs as nothing more than "growing pains," Picchietti said.
Many adults diagnosed with RLS report that their symptoms began in childhood. In the early 1990s, Picchietti began to notice that some children who came to his office because they had trouble sleeping or paying attention in school had symptoms of RLS. But there was scant research on the prevalence of RLS in children.
The new study included a rigorous analysis of participants' reported symptoms, and excluded those who did not meet all of the National Institutes of Health criteria for diagnosing children with RLS. A child who had periodic limb movements during sleep and no other symptoms of RLS would not be counted, for example. A child who reported leg cramps or growing pains would not be included unless he or she met all of the other diagnostic criteria for RLS.
Some parents are surprised to learn that conditions such as attention deficit hyperactivity disorder and depression appear to be more common in those diagnosed with RLS. Sleep disturbance, by itself, is known to aggravate ADHD and depression, which may explain the association, Picchietti said. But there may also be other reasons for the association.
Picchietti described the new findings as a major step forward in understanding how many children are affected by RLS. "But this is not the final answer," he said. "While some children with RLS had significant sleep disturbance and daytime symptoms, others did not. Which children would benefit from treatment and what those treatments should be are important issues to be addressed. Much more study is needed."
RESTLESS legs syndrome is under-diagnosed in children and could be an underlying cause of behavioural and sleep problems, experts say. A US survey of more than 10,000 families found 1.9% of children aged 8-11 years and 2% of children aged 12-17 years met the criteria for restless legs syndrome, but only 11% of these patients had been previously diagnosed with the condition. Sleep disturbances and a history of "growing pains" were significantly more common in children identified as having restless legs syndrome compared with controls, the data, published in Pediatrics (August), showed.
"These population-based data suggest that restless legs syndrome is prevalent and troublesome in adolescents, occurring more commonly than epilepsy or diabetes," the authors wrote.
Paediatric sleep physician Dr Arthur Teng said this was the first prevalence study to use proper diagnostic criteria, and showed the condition was being missed in many children. Restless legs syndrome could have many daytime presentations, including anxiety, attentional deficits, irritability, sleepiness and ADHD, said Dr Teng, head of the department of sleep medicine at Sydney Children's Hospital at Randwick. It was important to ask parents about their child's sleeping habits when they presented with these symptoms, he said.
"Ask about their bedtime routine, what time do they go to bed, what time does the child go to sleep, during sleep what happens," he said.
The study also identified a strong family association, with at least one biological parent reporting similar symptoms to the child in 70% of cases. While there were several pharmacological treatments available for adults with restless legs syndrome, Dr Teng said few of these were tested in, or suitable for, children. Iron supplements were one option in patients with ferritin levels less than 40µg/L, although evidence for their efficacy was "variable".
Science Daily are reporting: Restless Legs Syndrome Doubles Risk Of Stroke And Heart Disease, Study Shows
Quote:
People with restless legs syndrome (RLS) are twice as likely to have a stroke or heart disease compared to people without RLS, and the risk is greatest in those with the most frequent and severe symptoms, according to new research.
The study, the largest of its kind enrolling both men and women, involved 3,433 people with an average age of 68 who were enrolled in the Sleep Heart Health Study. Participants were diagnosed with RLS by detailed questionnaire and asked if they had been diagnosed with a variety of systemic diseases including cardiovascular disease and cerebrovascular disease. Of the participants, nearly seven percent of women and three percent of men had RLS.
The study found people with RLS were more than twice as likely to have cardiovascular disease or cerebrovascular disease. The results remained the same after adjusting for age, sex, race, body mass index, diabetes, high blood pressure, high blood pressure medication, HDL/LDL cholesterol levels, and smoking.
"The association of RLS with heart disease and stroke was strongest in those people who had RLS symptoms at least 16 times per month," said study author John W. Winkelman, MD, PhD, with Harvard Medical School in Boston. "There was also an increased risk among people who said their RLS symptoms were severe compared to those with less bothersome symptoms."....
Thought you might find this article useful:
"Treating restless legs
2007 Aug 7
GPs no longer have to search for a specialist neurologist for restless legs syndrome, because diagnosis and management can be achieved in general practice, says Dr Tony Brzezicki
Restless legs syndrome (RLS) is a common but poorly understood condition and, until recently, management has been difficult. Recent advances in therapy now make the accurate identification of RLS important.
It has long been recognised that RLS tends to run in families. At least three specific gene locations have been discovered, showing a strong genetic disposition to develop the syndrome.
Iron metabolism and in particular ferritin levels within the substantia nigra are known to be important, but exactly why is uncertain. Dopamine pathways are also involved. However, the evidence for these pathways being the underlying cause of RLS is conflicting.
Traditionally, dopaminergic drugs such as levodopa have been key therapeutic options. Now dopamine agonists are recommended as first-line treatments.
RLS to a lesser or greater degree afflicts up to 10% of the population [1].
Symptoms can vary with time, but tend to become more severe with age. As the onset is often insidious, many patients who become severely affected do not seek treatment, feeling there is nothing that can be done for them. Fortunately, this is no longer true.
The effect on people’s lives can be devastating. Sleep is disturbed or becomes almost impossible, meaning partners often move to separate bedrooms. Sufferers’ work is affected because of lack of sleep and poor concentration.
As keeping still becomes a nightmare for RLS patients, travel in cars and planes is not possible. Similarly, they avoid going to the theatre, cinema or other such events.
Diagnosis
Patients often become stressed, tired all the time and start to withdraw. It is certainly worthwhile enquiring about the symptoms of RLS in people who present with tiredness, insomnia and failure to cope. Patients can be mislabeled as suffering from depression, stress or ME syndrome.
To diagnose RLS, patients need to satisfy the International Restless Legs Syndrome Study Group’s four simple criteria:
● A need to move the legs, usually accompanied or caused by uncomfortable sensations in the legs;
● The need to move and unpleasant sensations being exclusively present or worse during periods of rest or inactivity;
● The need to move and unpleasant sensations being partially or totally relieved by movement, as long as the movement continues;
● The need to move or unpleasant sensations being generally worse in the evening or night, showing a strong circadian rhythm.
RLS can also occur as a secondary condition. The most common causes are:
● Iron-deficient anaemia;
● Pregnancy;
● End-stage renal disease.
It is therefore sensible to exclude iron deficiency by doing a ferritin test before firmly diagnosing RLS, to exclude a treatable secondary cause. RLS is also common in diabetes mellitus and can be mistaken for an autonomic neuropathy, which will be unresponsive to the usual treatments. So diagnosis is straightforward:
● Patient satisfies the four criteria;
● Ferritin is normal;
● Simple neurological examination is normal;
● There is no underlying cause for the RLS.
Treatment
Dopamine agonists
The treatments of choice are dopamine agonists. Two are licensed in the UK for the treatment of moderate to severe primary RLS: pramipexole and ropinirole. The Scottish Medicines Consortium, however, backs pramipexole in moderate to severe RLS, but ropinirole only in severe RLS [2,3].
The treatment algorithm for RLS is relatively simple. The first licensed medicine in the UK was pramipexole. Treatment is started with a single evening dose of 0.125mg (equivalent to 0.088mg base dose), and then slowly titrated upwards depending on response, every four to seven days, provided no
adverse side-effects occur.
The maximum daily dose of pramipexole is 0.75mg (equivalent to 0.54mg base dose) [4]. However, a good response is usually obtained at lower dose levels, 0.25mg (equivalent to 0.18mg base dose) being the usual dose. The most common side-effect of dopamine agonists is nausea.
The most frequently used treatment group in RLS has been dopaminergic agents (levodopa). Treatment is given as a single dose, usually at night. The drugs are very effective, but many patients develop one of two significant side-effects:
● Rebound – symptoms start appearing in the morning, in the afternoon or in the evening due to ongoing use of treatment;
● Augmentation – symptoms start appearing in the upper limbs.
These side-effects have been difficult to manage. Dosing schedules tend to become increasingly complex and the treatment regimens can become hard to manage.
For this reason RLS has become a tertiary care disease. This should no longer be a problem for the future. The early use of dopamine agonists will hopefully mean augmentation and rebound become a rare phenomenon.
Anti-epileptics
Anti-epileptics such as gabapentin can help if the RLS is particularly painful.
Clonazepam and zopiclone can be helpful if insomnia persists. Many patients are treated with drugs for insomnia or depression. However, fluoxetine and amitryptyline make RLS worse.
Non-drug interventions
Interventions that can help with RLS include:
Walking and stretching;
Hot or cold baths;
Relaxation and yoga;
Massaging the affected limbs;
Taking part in distracting activities, such as discussions or exercise;
Reducing caffeine and alcohol intake.
Referral to secondary or tertiary care is now only necessary if the diagnosis is in doubt or treatment fails, as augmentation or rebound can be very difficult to manage. The clear diagnostic criteria and good treatments now available make RLS a straightforward and satisfying condition to treat in primary care.
References
1. Phillips B, Young T et al. Arch Intern Med 2000; 160: 2137-41.
2. Scottish Medicines Consortium submission ( www.tinyurl.com/ 2kbhog). 3. Scottish Medicines Consortium submission ( www.tinyurl.com/ 3car33). 4. Boehringer Ingelheim Ltd ( www.tinyurl.com/36hb6f ).
Dr Brzezicki is a GP practising in Croydon
________________________________________
SYMPTOMS TO LOOK FOR
● The patient’s legs jump or twitch, often uncontrollably, at rest and especially at night
● Pain similar to neuropathic pain can be experienced, which presents like electric shocks, crawly sensations in the legs, fizzing under the skin, heat or cold
● All symptoms worsen towards the evening and are improved with exercise
● For some, staying still for any length of time becomes intolerable
● This combination of sleep, movement and neuropathic pain disorder is unique to RLS and symptoms tend to worsen with time
Diagnostic criteria for restless legs syndrome Essential criteria
1. An urge to move the legs (and occasionally the arms or other body parts) usually, but not always, accompanied by uncomfortable or unpleasant sensations
2. The symptoms begin or worsen during periods of rest or inactivity such as lying or sitting
3. Movement such as walking or stretching partially or totally relieves the symptoms at least as long as the activity continues
4. A circadian pattern: the symptoms are worse or only present in the evening or at night and this diurnal variation must have once been present if the symptoms are now so severe as to make diurnal variation unnoticeable
Supportive of the diagnosis
1. Family history
2. Response to dopaminergic therapy
3. Periodic limb movements during wakefulness or sleep
This device has just been granted a patent: Device to alleviate the symptoms of restless leg syndrome, restless arms syndrome, and foot and leg cramps
Quote:
A flexible foot relief pad that is wrapped about and secured to the individual's foot in order to relieve the symptoms of restless leg syndrome, restless arms, and foot and leg cramps includes a pliable cloth wrap having a foot engaging portion joined to a securing portion by a fold, with the foot engaging portion enclosing a cavity for holding therein a layered raised pressure application pad that applies pressure to select areas of the inner side and sole of the foot with the layered pad configured so that a portion of the pad extends transverse to the sole of the foot and a raised portion extends along the inner side of the foot for applying pressure to the specific muscle groups involved in restless leg syndrome. The flexible foot relief pad also includes adjustable securement members that wrap around and encompass both the foot and the relief pad for securing the pad to the foot, and the point of attachment for each securement member is adjustable thereby providing for the even application of pressure against the specific areas of the sole of the foot or for varying the amount of pressure applied to such areas on the sole of the foot.
I am not a physician, but I do have restless leg syndrome, and additionally experienced cramping of toes and feet daily since childhood. In my case, the entire problem was solved within a couple of days by taking powdered magnesium. No one was more surprised than I. I take 1 tablespoon dissolved in hot water every evening, (in the morning as well during ski vacations or when I am over-tired) and have no symptoms. Been taking it for over 10 years now.
I have no studies or medical evidence to prove it works for everyone, but it would be an inexpensive, non-drug solution to try.
Good to see someone not automatically diving for a pharmaceutical for a quick fix of a symptom. So often these problems are symptomatic of a lack some essential nutrient and never because the body is lacking a toxic drug. Good tip thank you
Geoff Boldero
Last edited by Admin : 24th January 2009 at 02:13 PM.
Reason: removed check4spam message